Alerus Financial »

SPDR S&P Pharmaceuticals shares owned by Alerus Financial

Quarter-by-quarter ownership of SPDR S&P Pharmaceuticals (XPH) shares owned by Alerus Financial from 13F filings

Historical chart of Alerus Financial investment in SPDR S&P Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Pharmaceuticals held by Alerus Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Pharmaceuticals by Alerus Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $18k 375 47.94
2025-06-30 $15k 375 40.58

More positions owned by Alerus Financial

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Dimensional Etf Trust World Ex Us Core (DFAX)
Ishares Tr Core Msci Total (IXUS)
Vanguard Malvern Fds Core Bd Etf (VCRB)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Alerus Finl (ALRS)
Apple (AAPL)
Broadcom (AVGO)
Ishares Tr Rus Mid Cap Etf (IWR)
Vanguard Scottsdale Fds Lg-term Cor Bd (VCLT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)

View all positions for Alerus Financial

Top funds holding SPDR S&P Pharmaceuticals

Morgan Stanley
Envestnet Asset Management
LPL Financial
First Citizens Bank & Trust
Envestnet Portfolio Solutions
Goldman Sachs Group
Susquehanna International
Wells Fargo & Company
Cetera Investment Advisers
Jpmorgan Chase & Co
CX Institutional
Wharton Business Group
Clark Capital Management Group
Bp Wealth Management
Bnp Paribas Arbitrage, Snc

View all funds holding SPDR S&P Pharmaceuticals